Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,292 | 61,389 | 27,357 | 99,501 | 52,826 |
| Marketable Securities | 65,047 | 74,234 | 44,146 | N/A | N/A |
| Receivables | 32,410 | 9,149 | 9,097 | 15,703 | 2,263 |
| Inventories | 9,489 | 6,406 | 6,170 | 2,671 | 567 |
| TOTAL | $171,772 | $161,321 | $95,195 | $130,628 | $63,988 |
| Non-Current Assets | |||||
| PPE Net | 3,943 | 2,951 | 3,422 | 3,701 | 1,771 |
| Other Non-Current Assets | 6,074 | 1,705 | 3,176 | 400 | 0 |
| TOTAL | $10,017 | $4,656 | $6,598 | $4,101 | $1,771 |
| Total Assets | $181,789 | $165,977 | $101,793 | $134,728 | $65,759 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 21,862 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,499 | 3,003 | 3,135 | 2,272 | 7,557 |
| Accrued Expenses | 26,792 | 13,961 | 14,369 | 7,783 | 5,616 |
| TOTAL | $62,457 | $24,331 | $24,902 | $18,946 | $17,302 |
| Non-Current Liabilities | |||||
| Long Term Debt | 27,971 | 49,860 | 49,772 | 29,662 | N/A |
| Deferred Revenues | 9,304 | 7,367 | 7,398 | 8,891 | 4,129 |
| Other Non-Current Liabilities | 4,443 | 3,167 | 1,364 | 0 | 0 |
| TOTAL | $76,333 | $100,294 | $96,881 | $66,929 | $37,557 |
| Total Liabilities | $138,790 | $124,625 | $121,783 | $85,875 | $54,858 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 129,061 | 126,704 | 124,004 | 113,123 | 112,094 |
| Common Shares | 128 | 126 | 115 | 113 | 104 |
| Retained earnings | -482,658 | -450,427 | -382,052 | -298,574 | -245,022 |
| Other shareholders' equity | -99 | -41 | 17 | 0 | 0 |
| TOTAL | $42,999 | $41,352 | $-19,990 | $48,854 | $10,900 |
| Total Liabilities And Equity | $181,789 | $165,977 | $101,793 | $134,728 | $65,759 |